When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. New Urine Test for Prostate Cancer May Help Reduce ... - AOL

   www.aol.com/lifestyle/urine-test-prostate-cancer...

   Researchers found that the test had a 95% sensitivity for prostate cancer of grade group 2 or greater, and 99% for grade group 3 or greater. “It does look impressive and exciting.

3. New prostate cancer imaging shows ‘extremely encouraging ...

   www.aol.com/prostate-cancer-imaging-shows...

   Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical trials. A team at Heriot-Watt University, Edinburgh, leading the ...

4. Doctors Explain What Prostate Cancer Screenings Involve

   www.aol.com/doctors-explain-prostate-cancer...

   How to Prepare for a Prostate Cancer Screening A PSA is like any routine blood test, Dr. Feng says. But you should refrain from ejaculating for at least 48 hours before the exam.

5. Prostate cancer screening - Wikipedia

   en.wikipedia.org/wiki/Prostate_cancer_screening

   Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in men without signs or symptoms. [1] [2] When abnormal prostate tissue or cancer is found early, it may be easier to treat and cure, but it is unclear if early detection reduces mortality rates.

6. Cancer screening - Wikipedia

   en.wikipedia.org/wiki/Cancer_screening

   Prostate cancer was estimated to be the second leading cause of death by cancer in the US in 2018. [35] There are different methods used in screening for prostate cancer prostate biopsy, prostate-specific antigen testing (PSA), and digital rectal examination (DRE). In the DRE the examiner inserts a finger in the rectum of the patient and ...

7. Active surveillance of prostate cancer - Wikipedia

   en.wikipedia.org/wiki/Active_surveillance_of...

   In a separate study of men from the pre prostate cancer screening era managed with watchful waiting (56% over age 70 years), progression to distant metastasis or prostate cancer death was 13.9% and 12.3%, respectively for Gleason score 6 or below, but considerably higher at 18.2 and 22.7%, 30% and 20%, 44.4% and 55.6% for Gleason 3+4, 4+3, and ...